Hyaluronic Acid Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Mexico, Germany, UK, Italy, France, Spain, China, India, Japan, South Korea, Thailand, Malaysia, Australia, Brazil, South Africa, UAE, Saudi Arabia), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Report ID: GMI4002

  Table of Contents
Summary Methodology

Hyaluronic Acid Market size is likely to witness a significant upsurge from 2019 to 2025 owing to its growing usage in cosmetics industry. It is mostly utilized in a plastic medical treatment as a lip filler and in skin care treatment for ulcers and recuperating wounds as a lotion, which is anticipated to drive its market demand over the projected period.
 

Hyaluronic acid, also called as hyaluronan is a nonsulfated glycosaminoglycan which is naturally produced in human body and is circulated usually in epithelial, connective and neural tissues. Its key function is to maintain water to keep your tissues moist and well lubricated. It is commercially synthesize using specific enzymes known as hyaluronic synthases (HAS) in a lab.
 

Dermal filler market size is predicted to upsurge significantly owing to rise in geriatric population undergoing dermal filling procedures to reinstate lost volume and uplift aging skin. Growing age results in loss of hyaluronic acid thus causing wrinkles and dehydration which will fuel product demand. In 2016, population aged 54 years and above accounted for over 48% of total patients which have undergone dermal filling procedures, as per study conducted by Dermatology Centre of Acadiana. Increasing awareness towards anti-aging cosmetics procedures is likely to positively impact the dermal filler treatment demand thereby driving hyaluronic acid market.
 

Global hyaluronic acid market size from osteoarthritis application is likely to register substantial gains over the forecast period. Increase in obese and aging population are propelling the detection osteoarthritis globally. It is the most common arthritis that causes swelling, pain and reduced motion in the joints. Supported regulatory standards by FDA regrading hyaluronic acid  approval for osteoarthritis treatment will favour industry growth.
 

The treatment procedure includes injecting hyaluronic acid into synovial fluid of hip and knee to ease joint pain and enable movement. These doses are prescribed according to severity and condition of the disease in the span of 2 to 5 weeks. Growing prevalence of osteoarthritis supported by increasing healthcare expenditure and technological advancement in the medical industry is anticipated to drive the market demand of hyaluronic acid market over the stipulated timeframe.
 

Global healthcare market is poised to surpass USD 11801 billion by 2025 owing to increasing populations along with greater frequency of chronic illnesses, and exponential developments in innovative digital technologies. Moreover, innovation in medical industry supported by minimal invasive surgical procedure is predicted to further boost the health care market thus driving the hyaluronic acid market demand.

 

Hyaluronic acid products are extremely efficient, but a mainstream patient is incapable to afford them due to of their high cost. Three-injection and single-injection cycles are premium priced making it challenging for them to appeal to customers in developing markets with a limited disposable income.
 

Cost concerns owing to complex manufacturing process may act as a major restricting factor towards industry profitability, thus affecting hyaluronic acid market price trends . Moreover, certain side  effects including itching, redness, tenderness, pain and bruising observed while undergoing hyaluronic acid treatment, which is likely to limit  industry growth
 

North America, led by Mexico, Canada and the U.S. hyaluronic acid market size, is estimated to rise in the projected time period. Strong healthcare industry due to high awareness towards health and rapid acceptance of new skin care treatments and technologies is anticipated to upsurge the product demand in this region.  
 

Europe, driven by UK, Spain, Italy, France and Germany hyaluronic acid market may register  strong gains owing to growth in cosmetics industry supported by favourable regulatory environment and new product development. Rising consumer inclination towards physical appearances have bolster demand for cosmetics and antiaging products, which is  anticipated to drive product demand.
 

Asia pacific, led by Australia, South Korea, Japan, India and China hyaluronic acid market is estimated to witness growth in cosmetics as well as healthcare industry. Japan has world’s highest geriatric population.  Furthermore, increase in occurrence of osteoarthritis and constant improvement observed in the healthcare amenities and infrastructure is likely to have positive impact on product demand. Increase in subsidy for R&D activities and higher acceptance of viscosupplementation agents in the region will propel industry growth.
 

Global hyaluronic acid market share is fragmented. Major players present in the industry includes Allergan, Smith & Nephew Plc ,Salix Pharmaceuticals, Sanofi (Genzyme), Seikagaku Corporation, Ferring Pharmaceuticals,  Galderma S.A., Anika Therapeutics, Inc., Zimmer Holdings and F. Hoffmann-La Roche.
 

Companies are primarily focusing on novel product development and capacity expansion to cater global  product demand. Manufacturers are extensively investing in new production techniques to produce sustainably and reduce environmental degradation. Initiatives along with competitive pricing may support increase in market share over projected time frame.
 

 Hyaluronic Acid Market, By Application, 2014-2025 (Tons) (USD Million)

  • Dermal Filler
  • Osteoarthritis      
  • Ophthalmic
  • Vesicoureteral Reflux

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Spain
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
    • Malaysia
    • Australia
  • Latin America
    • Brazil
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Company Profiles:

  • Allergan, Inc.
  • Salix Pharmaceuticals
  • Sanofi (Genzyme)
  • Seikagaku Corporation
  • Zimmer Holdings, Inc.
  • Galderma S.A.
  • Smith & Nephew Plc.
  • Anika Therapeutics, Inc.
  • Ferring Pharmaceuticals
  • F. Hoffman-La Roche Ltd.

 


What Information does this report contain?

Historical data coverage: 2014 to 2018; Growth Projections: 2019 to 2025.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.


Customize this Report

15% Free Customization
Share your Requirements

Customize this Report

Special Requests?

Inquire Before Buying
This site is protected by Trustwave's Trusted Commerce program Authorize.Net Merchant - Click to Verify BBB Rating - Click to Verify

Questions? Speak to an Analyst

Full Name *
Email *
Phone (With Country Code)
Message *
Are you human?
8 + 3 =

Your personal details are secure. Privacy Policy

Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability

Connect with our sales team

Chat With Us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info. I Agree